Wednesday, August 17, 2022
wellness India Expo
Home Tags Biopharma

Tag: biopharma

BioAsia 2022: FABA to host special panel on challenges in building...

The panelists include genius from Academics, Research and Healthcare

Scripps Research scientists unveil promising new approach to diabetes prevention

Experimental compound protects obese mice from diabetes-like metabolic changes

Dr. Bushra Ateeq wins Sun Pharma Science Foundation Research Award-2021

An IIT Kanpur professor, Dr. Ateeq’s research interest involves exploration of the genetic and epigenetic changes that initiate cancer and its progression

Emerging biopharma trends to watch for in 2022

Below are key trends that emerging biotech and emerging biopharma companies should look out for in 2022....................

Indian pharma industry growth in FY2022 estimated at 9-11%: ICRA

While cost optimization measures, lower overheads and R&D expenses supported margins in H1 FY2022, cost pressures are likely to weigh in on the margins going forward

AstraZeneca India grants 500 wishes of critically ill children

The initiative is an effort to reach out as many children between the age of 3 to 18 years as possible and leave them with joyous memories

“We are constantly strengthening our presence in India”

David Schwaas, Director, Marketing & Distribution, Biopharma, Freudenberg Medical shares details about the company's business operations, product offerings, future plans and much more.

ICT Mumbai to hold annual biosimilar workshop on 4-8 October

To be held in virtual mode as a 4-part webinar series organized over a span of 5 days, the workshop will impart training and insight directly from experts and academicians of the biopharmaceutical, diagnostic and vaccine industries.................

Agilent hosts first virtual ‘Total Agilent Experience’ in India

Annual scientific symposium showcased Agilent’s latest analytical solutions and provided a forum to network with Agilent technical teams..........................

Pact signed to manufacture anti-COVID drug 2-DG

Studies have shown that the anti-COVID oral drug 2- DG has resulted in quick recovery and reduction in oxygen dependence among moderately and severely affected patients..................